-
1.
公开(公告)号:US20130245092A1
公开(公告)日:2013-09-19
申请号:US13796884
申请日:2013-03-12
发明人: ERIC N. OLSON , EVA VAN ROOIJ
IPC分类号: C12N15/113
CPC分类号: C12N15/113 , A61K31/7105 , C12N2310/113 , C12N2310/141 , C12N2330/10
摘要: The present invention relates to the identification of two microRNAs, miR-499 and miR-208b, that repress fast skeletal muscle contractile protein genes. Expression of miR-499 and/or miR-208b can be used to repress fast fiber genes and activate slow fiber genes in the treatment of musculoskeletal disorders. Inhibition of miR-499 and/or miR-208b is proposed as a treatment for cardiac hypertrophy, myocardial infarction, and/or heart failure. Pharmaceutical compositions comprising antagonists and agonists of miR-499 and miR-208b function are also disclosed.
摘要翻译: 本发明涉及两种抑制快速骨骼肌收缩蛋白基因的微小RNA(miR-499和miR-208b)的鉴定。 miR-499和/或miR-208b的表达可用于抑制快速纤维基因并激活慢纤维基因以治疗肌肉骨骼疾病。 提出miR-499和/或miR-208b的抑制作为心脏肥大,心肌梗死和/或心力衰竭的治疗。 还公开了包含miR-499和miR-208b功能的拮抗剂和激动剂的药物组合物。
-
公开(公告)号:US20160145608A1
公开(公告)日:2016-05-26
申请号:US14592699
申请日:2015-01-08
发明人: ERIC N. OLSON , EVA VAN ROOIJ
IPC分类号: C12N15/113 , A61K45/06 , A61K31/713
CPC分类号: C12N15/113 , A01K67/0276 , A01K2207/30 , A01K2217/052 , A01K2217/075 , A01K2217/15 , A01K2217/206 , A01K2227/105 , A01K2267/0375 , A61K31/07 , A61K31/355 , A61K31/375 , A61K31/7105 , A61K31/712 , A61K31/7125 , A61K31/713 , A61K38/2242 , A61K39/3955 , A61K45/06 , A61L31/08 , A61L31/16 , A61L2300/258 , A61L2300/45 , A61L2420/06 , C12N9/16 , C12N15/8509 , C12N2310/113 , C12N2310/141 , C12N2310/315 , C12N2310/321 , C12N2310/346 , C12N2310/3515 , C12N2310/3521 , C12N2320/30 , C12N2320/31 , C12N2320/32 , C12N2330/10 , G06F19/00 , Y02A90/26 , A61K2300/00
摘要: The present invention relates to the identification of a microRNA family, designated miR-29a-c, that is a key regulator of fibrosis in cardiac tissue. The inventors show that members of the miR-29 family are down-regulated in the heart tissue in response to stress, and are up-regulated in heart tissue of mice that are resistant to both stress and fibrosis. Also provided are methods of modulating expression and activity of the miR-29 family of miRNAs as a treatment for fibrotic disease, including cardiac hypertrophy, skeletal muscle fibrosis other fibrosis related diseases and collagen loss-related disease.
摘要翻译: 本发明涉及一种称为miR-29a-c的微小RNA家族的鉴定,其是心脏组织中纤维化的关键调节剂。 发明人显示miR-29家族的成员在心脏组织中响应于应激被下调,并且在对应激和纤维化两者都有抗性的小鼠的心脏组织中上调。 还提供了调节miRNA的miR-29家族的表达和活性的方法,作为纤维化疾病的治疗,包括心脏肥大,骨骼肌纤维化等纤维化相关疾病和胶原损失相关疾病。
-
公开(公告)号:US20160145609A1
公开(公告)日:2016-05-26
申请号:US14592737
申请日:2015-01-08
发明人: ERIC N. OLSON , EVA VAN ROOIJ
IPC分类号: C12N15/113 , A61L31/16 , A61L31/08
CPC分类号: C12N15/113 , A01K67/0276 , A01K2207/30 , A01K2217/052 , A01K2217/075 , A01K2217/15 , A01K2217/206 , A01K2227/105 , A01K2267/0375 , A61K31/07 , A61K31/355 , A61K31/375 , A61K31/7105 , A61K31/712 , A61K31/7125 , A61K31/713 , A61K38/2242 , A61K39/3955 , A61K45/06 , A61L31/08 , A61L31/16 , A61L2300/258 , A61L2300/45 , A61L2420/06 , C12N9/16 , C12N15/8509 , C12N2310/113 , C12N2310/141 , C12N2310/315 , C12N2310/321 , C12N2310/346 , C12N2310/3515 , C12N2310/3521 , C12N2320/30 , C12N2320/31 , C12N2320/32 , C12N2330/10 , G06F19/00 , Y02A90/26 , A61K2300/00
摘要: The present invention relates to the identification of a microRNA family, designated miR-29a-c, that is a key regulator of fibrosis in cardiac tissue. The inventors show that members of the miR-29 family are down-regulated in the heart tissue in response to stress, and are up-regulated in heart tissue of mice that are resistant to both stress and fibrosis. Also provided are methods of modulating expression and activity of the miR-29 family of miRNAs as a treatment for fibrotic disease, including cardiac hypertrophy, skeletal muscle fibrosis other fibrosis related diseases and collagen loss-related disease.
-
公开(公告)号:US20160145607A1
公开(公告)日:2016-05-26
申请号:US14592686
申请日:2015-01-08
发明人: ERIC N. OLSON , EVA VAN ROOIJ
IPC分类号: C12N15/113
CPC分类号: C12N15/113 , A01K67/0276 , A01K2207/30 , A01K2217/052 , A01K2217/075 , A01K2217/15 , A01K2217/206 , A01K2227/105 , A01K2267/0375 , A61K31/07 , A61K31/355 , A61K31/375 , A61K31/7105 , A61K31/712 , A61K31/7125 , A61K31/713 , A61K38/2242 , A61K39/3955 , A61K45/06 , A61L31/08 , A61L31/16 , A61L2300/258 , A61L2300/45 , A61L2420/06 , C12N9/16 , C12N15/8509 , C12N2310/113 , C12N2310/141 , C12N2310/315 , C12N2310/321 , C12N2310/346 , C12N2310/3515 , C12N2310/3521 , C12N2320/30 , C12N2320/31 , C12N2320/32 , C12N2330/10 , G06F19/00 , Y02A90/26 , A61K2300/00
摘要: The present invention relates to the identification of a microRNA family, designated miR-29a-c, that is a key regulator of fibrosis in cardiac tissue. The inventors show that members of the miR-29 family are down-regulated in the heart tissue in response to stress, and are up-regulated in heart tissue of mice that are resistant to both stress and fibrosis. Also provided are methods of modulating expression and activity of the miR-29 family of miRNAs as a treatment for fibrotic disease, including cardiac hypertrophy, skeletal muscle fibrosis other fibrosis related diseases and collagen loss-related disease.
-
-
-